Oman pharmaceutical Product Co LLC - Oman

Welcome to

Oman pharmaceutical Product Co LLC

Free Member

Oman pharmaceutical Product Co LLC
Oman

Home
Company Info
Contact Us
Share your thoughts
Language
- English

Company Profile

Company Contact

Name:

Mr. Ronak Shah

E-mail:

Send Message

Mobile Number:

Phone Number:

Address:

Muscat, muscat
Oman

Average User Review

There is no review for this company - Write a review

Registration Date:

Jun. 25, 2024

Last Updated:

Nov. 22, 2012

Business Nature:

Manufacturing, Trade of Health & Beauty category

Want to contact this company?

Send Message

Your inquiry will be recorded in "Member Trade Mail".

Put on Company Partner

Recommend to your friends

Company Brief

Dear One,

Greetings and very good morning,

I am RONAK SHAH, from OMAN PHARMACEUTICALS PRODUCT CO LLC, MUSCAT, OMAN.

I take a chance to brief you about my company.

Oman pharmaceuticals Product Co LLC, is a Global Pharmaceutical company specializing in the development, production & marketing of generic and OTC pharmaceuticals in the GCC and worldwide.
The ultra-modern plant of Oman Pharmaceutical Products Co. LLC is located in Salalah, South of Oman.

OPP is the only pharmaceutical organization in GCC to have achieved this rare distinction of crossing regulatory approvals of some international authorities like
MHRA â € “ UK
TGA-Australia
RVO-Germany and
GCC-DR
US-FDA

Technical & Regulatory supports are available as an integral part of the company' s services.

OPP is interested in Global partnerships for Contract Manufacturing, In-Licensing, Co-Marketing and Joint ventures.

We already do export business with US, Europe, UK and Asian market.

Company is having large production capacity for example we have capacity to manufacture 870 million tablets/ annum.

For more introductory information you can go through our website that is Omanpharma.com .

Looking for your reply as a conformation to receive my communication.

I am familiar with this company and want to review it.

You have [3] new inquiries.